Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi-Goutières syndrome patients carrying RNASEH2 mutations

Cell Mol Immunol. 2021 Jun;18(6):1593-1595. doi: 10.1038/s41423-021-00657-0. Epub 2021 Mar 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / pharmacology
  • Autoimmune Diseases of the Nervous System / enzymology
  • Autoimmune Diseases of the Nervous System / genetics*
  • Autoimmune Diseases of the Nervous System / immunology*
  • Autophagy / drug effects
  • Child, Preschool
  • DNA / metabolism*
  • Humans
  • Hydroxychloroquine / pharmacology*
  • Lysosomes / drug effects
  • Lysosomes / metabolism
  • Mutation / genetics*
  • Nervous System Malformations / enzymology
  • Nervous System Malformations / genetics*
  • Nervous System Malformations / immunology*
  • Nucleotidyltransferases / metabolism
  • RNA / metabolism*
  • Ribonuclease H / genetics*

Substances

  • Antibodies
  • Hydroxychloroquine
  • RNA
  • DNA
  • Nucleotidyltransferases
  • cGAS protein, human
  • ribonuclease HII
  • Ribonuclease H

Supplementary concepts

  • Aicardi-Goutieres syndrome